Affymax Inc (AFFY)

Ticker: AFFY


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
WALKER JOHN PETER Non-Executive Director
Transaction date
Sale
Price
367.30
Quantity 83,237 +13.3%
Value US$521,286
WALKER JOHN PETER Non-Executive Director
Transaction date
Sale
Price
461.39
Quantity 30,136 -42.5%
Value US$2,692,439
Knapp Jeffrey H Chief Commercial Officer Officer
Transaction date
Planned sale
Price
26.73
Quantity 21,160 -13.4%
Value US$3,368,321
Orwin John A CEO Executive Director
Transaction date
Planned sale
Price
18.81
Quantity 6,366 -5.6%
Value US$119,744
Knapp Jeffrey H Chief Commercial Officer Officer
Transaction date
Planned sale
Price
21.25
Quantity 6,661 -33.7%
Value US$141,560
Knapp Jeffrey H Chief Commercial Officer Officer
Transaction date
Planned sale
Price
22.31
Quantity 6,694 -33.8%
Value US$149,316
LAPORTE KATHLEEN Non-Executive Director
Transaction date
Sale
Price
22.72
Quantity 5,000 -100.0%
Value US$113,600
Orwin John A CEO Executive Director
Transaction date
Planned sale
Price
24.22
Quantity 15,798 -14.7%
Value US$382,628
Venteicher Robert SVP, Technical Operations Officer
Transaction date
Planned sale
Price
24.00
Quantity 833 -3.2%
Value US$19,992
Knapp Jeffrey H Chief Commercial Officer Officer
Transaction date
Planned sale
Price
23.00
Quantity 1,000 -7.1%
Value US$23,000
Knapp Jeffrey H Chief Commercial Officer Officer
Transaction date
Planned sale
Price
22.62
Quantity 5,833 -30.8%
Value US$131,942
Venteicher Robert SVP, Technical Operations Officer
Transaction date
Planned sale
Price
23.63
Quantity 1,195 -4.6%
Value US$28,238
Venteicher Robert SVP, Technical Operations Officer
Transaction date
Planned sale
Price
25.74
Quantity 833 -3.2%
Value US$21,441
Venteicher Robert SVP, Technical Operations Officer
Transaction date
Planned sale
Price
27.00
Quantity 42,173 -62.8%
Value US$1,138,671
Knapp Jeffrey H Chief Commercial Officer Officer
Transaction date
Planned sale
Price
26.71
Quantity 10,012 -43.3%
Value US$267,370
Venteicher Robert SVP, Technical Operations Officer
Transaction date
Planned sale
Price
27.00
Quantity 20,014 -44.5%
Value US$540,378
Venteicher Robert SVP, Technical Operations Officer
Transaction date
Planned sale
Price
25.00
Quantity 32,937 -56.9%
Value US$823,425
Venteicher Robert SVP, Technical Operations Officer
Transaction date
Planned sale
Price
24.00
Quantity 17,974 -23.7%
Value US$431,376
Knapp Jeffrey H Chief Commercial Officer Officer
Transaction date
Planned sale
Price
25.00
Quantity 914 -6.5%
Value US$22,850
Knapp Jeffrey H Chief Commercial Officer Officer
Transaction date
Planned sale
Price
26.00
Quantity 14,100 -50.1%
Value US$366,600
Knapp Jeffrey H Chief Commercial Officer Officer
Transaction date
Planned sale
Price
23.24
Quantity 12,000 -46.1%
Value US$278,880
Venteicher Robert SVP, Technical Operations Officer
Transaction date
Planned sale
Price
23.00
Quantity 10,938 -30.4%
Value US$251,574
Venteicher Robert SVP, Technical Operations Officer
Transaction date
Planned sale
Price
22.00
Quantity 11,789 -32.1%
Value US$259,358
Orwin John A CEO Executive Director
Transaction date
Planned sale
Price
22.50
Quantity 41,664 -31.2%
Value US$937,440
Venteicher Robert SVP, Technical Operations Officer
Transaction date
Planned sale
Price
22.00
Quantity 100 -0.4%
Value US$2,200
Venteicher Robert SVP, Technical Operations Officer
Transaction date
Planned sale
Price
21.14
Quantity 508 -2.0%
Value US$10,739
Orwin John A CEO Executive Director
Transaction date
Planned sale
Price
21.04
Quantity 11,632 -11.2%
Value US$244,737
Venteicher Robert SVP, Technical Operations Officer
Transaction date
Planned sale
Price
22.00
Quantity 4,200 -14.4%
Value US$92,400
Venteicher Robert SVP, Technical Operations Officer
Transaction date
Planned sale
Price
21.00
Quantity 4,062 -14.0%
Value US$85,302
Venteicher Robert SVP, Technical Operations Officer
Transaction date
Planned sale
Price
20.82
Quantity 10,000 -25.6%
Value US$208,200
Knapp Jeffrey H Chief Commercial Officer Officer
Transaction date
Sale
Price
20.75
Quantity 6,662 -32.2%
Value US$138,269
Duliege Anne-Marie Chief Medical Officer Officer
Transaction date
Planned sale
Price
20.00
Quantity 23,227 -41.4%
Value US$464,540
Orwin John A CEO Executive Director
Transaction date
Planned sale
Price
20.00
Quantity 48,997 -34.8%
Value US$979,940
Knapp Jeffrey H Chief Commercial Officer Officer
Transaction date
Planned sale
Price
20.00
Quantity 19,663 -58.3%
Value US$393,260
CROSS HERB Chief Financial Officer Officer
Transaction date
Planned sale
Price
18.50
Quantity 5,000 -30.7%
Value US$92,500
Knapp Jeffrey H Chief Commercial Officer Officer
Transaction date
Planned sale
Price
17.50
Quantity 1,903 -11.3%
Value US$33,302
Knapp Jeffrey H Chief Commercial Officer Officer
Transaction date
Planned sale
Price
17.50
Quantity 237 -1.4%
Value US$4,148
Knapp Jeffrey H Chief Commercial Officer Officer
Transaction date
Planned sale
Price
17.50
Quantity 677 -3.8%
Value US$11,848
Knapp Jeffrey H Chief Commercial Officer Officer
Transaction date
Planned sale
Price
17.50
Quantity 18,750 -51.3%
Value US$328,125
Orwin John A CEO Executive Director
Transaction date
Planned sale
Price
17.50
Quantity 48,996 -34.7%
Value US$857,430
Knapp Jeffrey H Chief Commercial Officer Officer
Transaction date
Planned sale
Price
16.48
Quantity 4,584 -20.5%
Value US$75,531
Orwin John A CEO Executive Director
Transaction date
Planned sale
Price
16.31
Quantity 1,100 -1.2%
Value US$17,941
CROSS HERB Chief Financial Officer Officer
Transaction date
Planned sale
Price
17.00
Quantity 10,000 -50.0%
Value US$170,000
Knapp Jeffrey H Chief Commercial Officer Officer
Transaction date
Planned sale
Price
16.29
Quantity 4,584 -17.0%
Value US$74,681
Knapp Jeffrey H Chief Commercial Officer Officer
Transaction date
Planned sale
Price
15.00
Quantity 5,665 -20.2%
Value US$84,975
Orwin John A CEO Executive Director
Transaction date
Planned sale
Price
15.00
Quantity 18,700 -16.9%
Value US$280,500
CROSS HERB Chief Financial Officer Officer
Transaction date
Planned sale
Price
15.50
Quantity 15,000 -60.0%
Value US$232,500
Knapp Jeffrey H Chief Commercial Officer Officer
Transaction date
Planned sale
Price
13.10
Quantity 3,000 -11.4%
Value US$39,300
Knapp Jeffrey H Chief Commercial Officer Officer
Transaction date
Planned sale
Price
14.27
Quantity 3,000 -11.4%
Value US$42,824
Knapp Jeffrey H Chief Commercial Officer Officer
Transaction date
Planned sale
Price
12.50
Quantity 2,414 -9.4%
Value US$30,175
Knapp Jeffrey H Chief Commercial Officer Officer
Transaction date
Planned sale
Price
11.86
Quantity 2,414 -9.1%
Value US$28,630
Orwin John A CEO Executive Director
Transaction date
Planned sale
Price
15.70
Quantity 8,200 -5.0%
Value US$128,740
WALKER JOHN PETER Non-Executive Director
Transaction date
Purchase
Price
6.09
Quantity 14,000 +551.2%
Value US$85,260
WALKER JOHN PETER Non-Executive Director
Transaction date
Purchase
Price
6.34
Quantity 2,540 +inf%
Value US$16,104
Duliege Anne-Marie Chief Medical Officer Officer
Transaction date
Sale
Price
5.17
Quantity 823 -3.2%
Value US$4,255
LAPORTE KATHLEEN Non-Executive Director
Transaction date
Sale
Price
6.83
Quantity 41,303 -100.0%
Value US$282,145
LAPORTE KATHLEEN Non-Executive Director
Transaction date
Sale
Price
6.90
Quantity 51,797 -55.6%
Value US$357,617
LAPORTE KATHLEEN Non-Executive Director
Transaction date
Sale
Price
7.03
Quantity 746,818 -88.9%
Value US$5,251,176
LAPORTE KATHLEEN Non-Executive Director
Transaction date
Sale
Price
7.03
Quantity 7,131 -0.8%
Value US$50,131
LAPORTE KATHLEEN Non-Executive Director
Transaction date
Sale
Price
7.01
Quantity 47,541 -5.3%
Value US$333,025
LAPORTE KATHLEEN Non-Executive Director
Transaction date
Sale
Price
7.01
Quantity 17,200 -1.9%
Value US$120,486
LAPORTE KATHLEEN Non-Executive Director
Transaction date
Sale
Price
7.09
Quantity 250,000 -21.5%
Value US$1,772,500
LAPORTE KATHLEEN Non-Executive Director
Transaction date
Sale
Price
7.22
Quantity 450,000 -27.9%
Value US$3,248,550
LAPORTE KATHLEEN Non-Executive Director
Transaction date
Sale
Price
7.54
Quantity 82,309 -4.9%
Value US$620,363
LAPORTE KATHLEEN Non-Executive Director
Transaction date
Sale
Price
7.58
Quantity 80,308 -4.5%
Value US$608,333
LAPORTE KATHLEEN Non-Executive Director
Transaction date
Sale
Price
7.83
Quantity 450,000 -20.2%
Value US$3,522,150
Morris Arlene CEO Executive Director
Transaction date
Planned sale
Price
25.06
Quantity 51,830 -100.0%
Value US$1,299,052
Morris Arlene CEO Executive Director
Transaction date
Planned sale
Price
25.01
Quantity 100 -100.0%
Value US$2,501
Morris Arlene CEO Executive Director
Transaction date
Planned sale
Price
25.00
Quantity 966 -90.6%
Value US$24,150
Morris Arlene CEO Executive Director
Transaction date
Planned sale
Price
25.05
Quantity 41,021 -100.0%
Value US$1,027,396
Morris Arlene CEO Executive Director
Transaction date
Planned sale
Price
25.40
Quantity 80,908 -100.0%
Value US$2,055,063
Morris Arlene CEO Executive Director
Transaction date
Planned sale
Price
26.05
Quantity 28,400 -26.0%
Value US$739,820
Morris Arlene CEO Executive Director
Transaction date
Planned sale
Price
25.02
Quantity 100 -100.0%
Value US$2,502
Morris Arlene CEO Executive Director
Transaction date
Planned sale
Price
25.01
Quantity 400 -80.0%
Value US$10,004
Morris Arlene CEO Executive Director
Transaction date
Planned sale
Price
25.00
Quantity 29,581 -98.3%
Value US$739,525
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2013-08-29 2013-08-28 S Sale WALKER JOHN PETER Non-Executive Director
83,237 +13.3%
367.30
US$521,286
83,237 +13.3% 367.30 US$521,286
2013-08-29 2013-08-28 S Sale WALKER JOHN PETER Non-Executive Director
30,136 -42.5%
461.39
US$2,692,439
30,136 -42.5% 461.39 US$2,692,439
2013-02-19 2013-02-15 PlS Planned sale Knapp Jeffrey H

Chief Commercial Officer

Officer
21,160 -13.4%
26.73
US$3,368,321
21,160 -13.4% 26.73 US$3,368,321
2013-02-05 2013-02-01 PlS Planned sale Orwin John A

CEO

Executive Director
6,366 -5.6%
18.81
US$119,744
6,366 -5.6% 18.81 US$119,744
2013-01-17 2013-01-15 PlS Planned sale Knapp Jeffrey H

Chief Commercial Officer

Officer
6,661 -33.7%
21.25
US$141,560
6,661 -33.7% 21.25 US$141,560
2012-12-19 2012-12-17 PlS Planned sale Knapp Jeffrey H

Chief Commercial Officer

Officer
6,694 -33.8%
22.31
US$149,316
6,694 -33.8% 22.31 US$149,316
2012-12-18 2012-12-14 S Sale LAPORTE KATHLEEN Non-Executive Director
5,000 -100.0%
22.72
US$113,600
5,000 -100.0% 22.72 US$113,600
2012-12-04 2012-12-03 PlS Planned sale Orwin John A

CEO

Executive Director
15,798 -14.7%
24.22
US$382,628
15,798 -14.7% 24.22 US$382,628
2012-11-27 2012-11-23 PlS Planned sale Venteicher Robert

SVP, Technical Operations

Officer
833 -3.2%
24.00
US$19,992
833 -3.2% 24.00 US$19,992
2012-11-19 2012-11-19 PlS Planned sale Knapp Jeffrey H

Chief Commercial Officer

Officer
1,000 -7.1%
23.00
US$23,000
1,000 -7.1% 23.00 US$23,000
2012-11-19 2012-11-15 PlS Planned sale Knapp Jeffrey H

Chief Commercial Officer

Officer
5,833 -30.8%
22.62
US$131,942
5,833 -30.8% 22.62 US$131,942
2012-11-05 2012-11-02 PlS Planned sale Venteicher Robert

SVP, Technical Operations

Officer
1,195 -4.6%
23.63
US$28,238
1,195 -4.6% 23.63 US$28,238
2012-10-25 2012-10-23 PlS Planned sale Venteicher Robert

SVP, Technical Operations

Officer
833 -3.2%
25.74
US$21,441
833 -3.2% 25.74 US$21,441
2012-10-16 2012-10-15 PlS Planned sale Venteicher Robert

SVP, Technical Operations

Officer
42,173 -62.8%
27.00
US$1,138,671
42,173 -62.8% 27.00 US$1,138,671
2012-10-16 2012-10-15 PlS Planned sale Knapp Jeffrey H

Chief Commercial Officer

Officer
10,012 -43.3%
26.71
US$267,370
10,012 -43.3% 26.71 US$267,370
2012-10-12 2012-10-11 PlS Planned sale Venteicher Robert

SVP, Technical Operations

Officer
20,014 -44.5%
27.00
US$540,378
20,014 -44.5% 27.00 US$540,378
2012-10-12 2012-10-10 PlS Planned sale Venteicher Robert

SVP, Technical Operations

Officer
32,937 -56.9%
25.00
US$823,425
32,937 -56.9% 25.00 US$823,425
2012-10-12 2012-10-10 PlS Planned sale Venteicher Robert

SVP, Technical Operations

Officer
17,974 -23.7%
24.00
US$431,376
17,974 -23.7% 24.00 US$431,376
2012-10-12 2012-10-10 PlS Planned sale Knapp Jeffrey H

Chief Commercial Officer

Officer
914 -6.5%
25.00
US$22,850
914 -6.5% 25.00 US$22,850
2012-10-12 2012-10-10 PlS Planned sale Knapp Jeffrey H

Chief Commercial Officer

Officer
14,100 -50.1%
26.00
US$366,600
14,100 -50.1% 26.00 US$366,600
2012-10-09 2012-10-09 PlS Planned sale Knapp Jeffrey H

Chief Commercial Officer

Officer
12,000 -46.1%
23.24
US$278,880
12,000 -46.1% 23.24 US$278,880
2012-10-09 2012-10-09 PlS Planned sale Venteicher Robert

SVP, Technical Operations

Officer
10,938 -30.4%
23.00
US$251,574
10,938 -30.4% 23.00 US$251,574
2012-10-09 2012-10-05 PlS Planned sale Venteicher Robert

SVP, Technical Operations

Officer
11,789 -32.1%
22.00
US$259,358
11,789 -32.1% 22.00 US$259,358
2012-10-09 2012-10-05 PlS Planned sale Orwin John A

CEO

Executive Director
41,664 -31.2%
22.50
US$937,440
41,664 -31.2% 22.50 US$937,440
2012-10-04 2012-10-04 PlS Planned sale Venteicher Robert

SVP, Technical Operations

Officer
100 -0.4%
22.00
US$2,200
100 -0.4% 22.00 US$2,200
2012-10-04 2012-10-02 PlS Planned sale Venteicher Robert

SVP, Technical Operations

Officer
508 -2.0%
21.14
US$10,739
508 -2.0% 21.14 US$10,739
2012-10-03 2012-10-01 PlS Planned sale Orwin John A

CEO

Executive Director
11,632 -11.2%
21.04
US$244,737
11,632 -11.2% 21.04 US$244,737
2012-09-21 2012-09-21 PlS Planned sale Venteicher Robert

SVP, Technical Operations

Officer
4,200 -14.4%
22.00
US$92,400
4,200 -14.4% 22.00 US$92,400
2012-09-21 2012-09-19 PlS Planned sale Venteicher Robert

SVP, Technical Operations

Officer
4,062 -14.0%
21.00
US$85,302
4,062 -14.0% 21.00 US$85,302
2012-09-21 2012-09-19 PlS Planned sale Venteicher Robert

SVP, Technical Operations

Officer
10,000 -25.6%
20.82
US$208,200
10,000 -25.6% 20.82 US$208,200
2012-09-17 2012-09-17 S Sale Knapp Jeffrey H

Chief Commercial Officer

Officer
6,662 -32.2%
20.75
US$138,269
6,662 -32.2% 20.75 US$138,269
2012-09-17 2012-09-13 PlS Planned sale Duliege Anne-Marie

Chief Medical Officer

Officer
23,227 -41.4%
20.00
US$464,540
23,227 -41.4% 20.00 US$464,540
2012-09-17 2012-09-13 PlS Planned sale Orwin John A

CEO

Executive Director
48,997 -34.8%
20.00
US$979,940
48,997 -34.8% 20.00 US$979,940
2012-09-17 2012-09-13 PlS Planned sale Knapp Jeffrey H

Chief Commercial Officer

Officer
19,663 -58.3%
20.00
US$393,260
19,663 -58.3% 20.00 US$393,260
2012-09-07 2012-09-05 PlS Planned sale CROSS HERB

Chief Financial Officer

Officer
5,000 -30.7%
18.50
US$92,500
5,000 -30.7% 18.50 US$92,500
2012-08-22 2012-08-20 PlS Planned sale Knapp Jeffrey H

Chief Commercial Officer

Officer
1,903 -11.3%
17.50
US$33,302
1,903 -11.3% 17.50 US$33,302
2012-08-22 2012-08-20 PlS Planned sale Knapp Jeffrey H

Chief Commercial Officer

Officer
237 -1.4%
17.50
US$4,148
237 -1.4% 17.50 US$4,148
2012-08-22 2012-08-20 PlS Planned sale Knapp Jeffrey H

Chief Commercial Officer

Officer
677 -3.8%
17.50
US$11,848
677 -3.8% 17.50 US$11,848
2012-08-22 2012-08-20 PlS Planned sale Knapp Jeffrey H

Chief Commercial Officer

Officer
18,750 -51.3%
17.50
US$328,125
18,750 -51.3% 17.50 US$328,125
2012-08-22 2012-08-20 PlS Planned sale Orwin John A

CEO

Executive Director
48,996 -34.7%
17.50
US$857,430
48,996 -34.7% 17.50 US$857,430
2012-08-15 2012-08-15 PlS Planned sale Knapp Jeffrey H

Chief Commercial Officer

Officer
4,584 -20.5%
16.48
US$75,531
4,584 -20.5% 16.48 US$75,531
2012-08-03 2012-08-01 PlS Planned sale Orwin John A

CEO

Executive Director
1,100 -1.2%
16.31
US$17,941
1,100 -1.2% 16.31 US$17,941
2012-07-17 2012-07-17 PlS Planned sale CROSS HERB

Chief Financial Officer

Officer
10,000 -50.0%
17.00
US$170,000
10,000 -50.0% 17.00 US$170,000
2012-07-17 2012-07-16 PlS Planned sale Knapp Jeffrey H

Chief Commercial Officer

Officer
4,584 -17.0%
16.29
US$74,681
4,584 -17.0% 16.29 US$74,681
2012-07-17 2012-07-13 PlS Planned sale Knapp Jeffrey H

Chief Commercial Officer

Officer
5,665 -20.2%
15.00
US$84,975
5,665 -20.2% 15.00 US$84,975
2012-07-17 2012-07-13 PlS Planned sale Orwin John A

CEO

Executive Director
18,700 -16.9%
15.00
US$280,500
18,700 -16.9% 15.00 US$280,500
2012-07-17 2012-07-13 PlS Planned sale CROSS HERB

Chief Financial Officer

Officer
15,000 -60.0%
15.50
US$232,500
15,000 -60.0% 15.50 US$232,500
2012-06-19 2012-06-15 PlS Planned sale Knapp Jeffrey H

Chief Commercial Officer

Officer
3,000 -11.4%
13.10
US$39,300
3,000 -11.4% 13.10 US$39,300
2012-05-16 2012-05-15 PlS Planned sale Knapp Jeffrey H

Chief Commercial Officer

Officer
3,000 -11.4%
14.27
US$42,824
3,000 -11.4% 14.27 US$42,824
2012-04-26 2012-04-24 PlS Planned sale Knapp Jeffrey H

Chief Commercial Officer

Officer
2,414 -9.4%
12.50
US$30,175
2,414 -9.4% 12.50 US$30,175
2012-04-18 2012-04-16 PlS Planned sale Knapp Jeffrey H

Chief Commercial Officer

Officer
2,414 -9.1%
11.86
US$28,630
2,414 -9.1% 11.86 US$28,630
2012-03-29 2012-03-27 PlS Planned sale Orwin John A

CEO

Executive Director
8,200 -5.0%
15.70
US$128,740
8,200 -5.0% 15.70 US$128,740
2011-12-20 2011-12-19 B Purchase WALKER JOHN PETER Non-Executive Director
14,000 +551.2%
6.09
US$85,260
14,000 +551.2% 6.09 US$85,260
2011-12-20 2011-12-19 B Purchase WALKER JOHN PETER Non-Executive Director
2,540 +inf%
6.34
US$16,104
2,540 +inf% 6.34 US$16,104
2011-11-03 2011-11-01 S Sale Duliege Anne-Marie

Chief Medical Officer

Officer
823 -3.2%
5.17
US$4,255
823 -3.2% 5.17 US$4,255
2011-07-05 2011-07-01 S Sale LAPORTE KATHLEEN Non-Executive Director
41,303 -100.0%
6.83
US$282,145
41,303 -100.0% 6.83 US$282,145
2011-07-05 2011-06-30 S Sale LAPORTE KATHLEEN Non-Executive Director
51,797 -55.6%
6.90
US$357,617
51,797 -55.6% 6.90 US$357,617
2011-06-30 2011-06-28 S Sale LAPORTE KATHLEEN Non-Executive Director
746,818 -88.9%
7.03
US$5,251,176
746,818 -88.9% 7.03 US$5,251,176
2011-05-18 2011-05-16 S Sale LAPORTE KATHLEEN Non-Executive Director
7,131 -0.8%
7.03
US$50,131
7,131 -0.8% 7.03 US$50,131
2011-01-14 2011-01-14 S Sale LAPORTE KATHLEEN Non-Executive Director
47,541 -5.3%
7.01
US$333,025
47,541 -5.3% 7.01 US$333,025
2011-01-14 2011-01-13 S Sale LAPORTE KATHLEEN Non-Executive Director
17,200 -1.9%
7.01
US$120,486
17,200 -1.9% 7.01 US$120,486
2011-01-14 2011-01-12 S Sale LAPORTE KATHLEEN Non-Executive Director
250,000 -21.5%
7.09
US$1,772,500
250,000 -21.5% 7.09 US$1,772,500
2011-01-12 2011-01-11 S Sale LAPORTE KATHLEEN Non-Executive Director
450,000 -27.9%
7.22
US$3,248,550
450,000 -27.9% 7.22 US$3,248,550
2011-01-12 2011-01-10 S Sale LAPORTE KATHLEEN Non-Executive Director
82,309 -4.9%
7.54
US$620,363
82,309 -4.9% 7.54 US$620,363
2010-08-11 2010-08-10 S Sale LAPORTE KATHLEEN Non-Executive Director
80,308 -4.5%
7.58
US$608,333
80,308 -4.5% 7.58 US$608,333
2010-08-11 2010-08-09 S Sale LAPORTE KATHLEEN Non-Executive Director
450,000 -20.2%
7.83
US$3,522,150
450,000 -20.2% 7.83 US$3,522,150
2010-05-19 2010-05-18 PlS Planned sale Morris Arlene

CEO

Executive Director
51,830 -100.0%
25.06
US$1,299,052
51,830 -100.0% 25.06 US$1,299,052
2010-05-19 2010-05-17 PlS Planned sale Morris Arlene

CEO

Executive Director
100 -100.0%
25.01
US$2,501
100 -100.0% 25.01 US$2,501
2010-05-19 2010-05-17 PlS Planned sale Morris Arlene

CEO

Executive Director
966 -90.6%
25.00
US$24,150
966 -90.6% 25.00 US$24,150
2010-05-13 2010-05-13 PlS Planned sale Morris Arlene

CEO

Executive Director
41,021 -100.0%
25.05
US$1,027,396
41,021 -100.0% 25.05 US$1,027,396
2010-05-13 2010-05-12 PlS Planned sale Morris Arlene

CEO

Executive Director
80,908 -100.0%
25.40
US$2,055,063
80,908 -100.0% 25.40 US$2,055,063
2010-05-13 2010-05-12 PlS Planned sale Morris Arlene

CEO

Executive Director
28,400 -26.0%
26.05
US$739,820
28,400 -26.0% 26.05 US$739,820
2010-05-13 2010-05-11 PlS Planned sale Morris Arlene

CEO

Executive Director
100 -100.0%
25.02
US$2,502
100 -100.0% 25.02 US$2,502
2010-05-13 2010-05-11 PlS Planned sale Morris Arlene

CEO

Executive Director
400 -80.0%
25.01
US$10,004
400 -80.0% 25.01 US$10,004
2010-05-13 2010-05-11 PlS Planned sale Morris Arlene

CEO

Executive Director
29,581 -98.3%
25.00
US$739,525
29,581 -98.3% 25.00 US$739,525
Explore more

More insider trading research around Affymax Inc